Dechra Isaderm Vet.

Isaderm Vet. is a prescription veterinary topical gel containing fusidic acid and betamethasone, formulated to treat localized skin infections such as wet eczema (acute moist dermatitis) in dogs.

The formulation originates from Denmark, developed out of LEO Pharma's renowned dermatological fusidic acid portfolio (historically marketed under Leo Animal Health / Dechra Veterinary Products). Manufacturing of veterinary products under this line takes place predominantly in Denmark.

Today, the brand belongs to Dechra Pharmaceuticals, a major global veterinary pharmaceuticals business founded in the United Kingdom. In early 2024, Dechra was acquired by the global private equity investment firm EQT, based in Sweden, alongside co-investor ADIA.